Increased risk of wheeze and asthma in young children whose mothers smoke during the pregnancySeptember 22, 2000[Wheeze associated with prenatal tobacco smoke exposure: a prospective, longitudinal study] Archives Of Disease In Childhood, 2000; 83: 307-12 Young children may be at increased risk of wheeze and asthma if their mothers smoke during pregnancy, finds research in the Archives of Disease in Childhood. This held true irrespective of the effects of exposure to environmental tobacco smoke. Over 8500 mothers were surveyed about their smoking habits during pregnancy and the respiratory health of their children, as part of the Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC). Around one in five children were wheezy between the ages of 18 and 30 months, the risk being higher if the mother smoked while pregnant. This is an important period for determining levels of risk, say the authors, because earlier on in a child?s life, wheeze could be caused by infections. Environmental tobacco smoke (ETS) and smoking during pregnancy seemed to confer similar levels of risk for wheeze in infancy and early childhood. But while the amount of exposure to ETS increased the corresponding risk of asthma or wheeze, light smoking during pregnancy conferred the same level of risk as heavier smoking. Applied across the population, smoking during pregnancy and ETS are likely to account for around 1.5 per cent of wheeziness in all young children, say the authors. Four out of 10 children were wheezy at some point throughout the 30 months of monitoring, attributable to other identifiable risk factors, such as a family history of asthma, premature delivery, male sex of the child, and living in rented accommodation. Wales Bangor, University of |
|||||||||||||||||||||
| Related Asthma Current Events and Asthma News Articles Exposures to metals and diesel emissions in air linked to respiratory symptoms in children Exposure shortly after birth to ambient metals from residential heating oil combustion and particles from diesel emissions are associated with respiratory symptoms in young inner city children. Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later New research presents strong evidence that the "synergistic" effect of early-life exposure to both outdoor traffic-related pollution and indoor endotoxin causes more harm to developing lungs than one or the other exposure alone. Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. Ancestry attracts, but love is blind People preferentially marry those with similar ancestry, but their decisions are not necessarily based on hair, eye or skin colour. Common plastics chemicals linked to ADHD symptoms Phthalates are important components of many consumer products, including toys, cleaning materials, plastics, and personal care items. Asthma a significant risk factor for complications in children with H1N1 A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu. Mother's Depression a Risk Factor in Childhood Asthma Symptoms, Study Suggests Asthma symptoms can worsen in children with depressed mothers, according to research from Johns Hopkins Children's Center published online in the Journal of Pediatric Psychology. Sweet -- sugared polymer a new weapon against allergies and asthma Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities. More Asthma Current Events and Asthma News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||